Outcome of MS relapses in the era of disease-modifying therapy

Overview of attention for article published in BMC Neurology, August 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 13,767 followers.

New study recommends incorporating scheduled follow-up visits into routine #MS relapse management https://t.co/LlRcryfydl #bmcneurol

RT @OhioHealthMS: Outcome of MS relapses in the era of disease-modifying therapy. - PubMed - NCBI https://t.co/h8Y9ShQNWs

Outcome of MS relapses in the era of disease-modifying therapy. https://t.co/Itd6YEoVvE

Outcome of MS relapses in the era of disease-modifying therapy. - PubMed - NCBI https://t.co/h8Y9ShQNWs

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.